Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobukazu Fujimoto

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Clinical & Experimental Metastasis|December 2, 2015
Brain metastases in malignant pleural mesotheliomaTomoko Yamagishi, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Drug Discoveries & Therapeutics|February 16, 2016
Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case reportNaofumi Hara, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2004
Complexity in the treatment of pulmonary large cell neuroendocrine carcinomaToshiyuki Kozuki, Nobukazu Fujimoto, Hiroshi Ueoka, et al.
Pulmonary Medicine|December 23, 2015
Clinical Investigation of Benign Asbestos Pleural EffusionNobukazu Fujimoto, Kenichi Gemba, Keisuke Aoe, et al.
Anticancer Research|December 12, 2003
Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancerNobukazu Fujimoto, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancerKeiichi Fujiwara, Nobukazu Fujimoto, Masahiro Tabata, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2015
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesotheliomaTomoko Yamagishi, Nobukazu Fujimoto, Hideyuki Nishi, et al.
Cancer Science|December 8, 2011
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaMasanori Fujii, Nobukazu Fujimoto, Akio Hiraki, et al.
JTO Clinical and Research Reports|September 30, 2021
Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT StudyNobukazu Fujimoto, Morihito Okada, Takashi Kijima, et al.
Oncology Reports|January 5, 2007
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationKatsuyuki Hotta, Masahiro Tabata, Katsuyuki Kiura, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Clinical & Experimental Metastasis|December 2, 2015
Brain metastases in malignant pleural mesotheliomaTomoko Yamagishi, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Drug Discoveries & Therapeutics|February 16, 2016
Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case reportNaofumi Hara, Nobukazu Fujimoto, Yosuke Miyamoto, et al.
Journal of Cancer Research and Clinical Oncology|November 13, 2004
Complexity in the treatment of pulmonary large cell neuroendocrine carcinomaToshiyuki Kozuki, Nobukazu Fujimoto, Hiroshi Ueoka, et al.
Pulmonary Medicine|December 23, 2015
Clinical Investigation of Benign Asbestos Pleural EffusionNobukazu Fujimoto, Kenichi Gemba, Keisuke Aoe, et al.
Anticancer Research|December 12, 2003
Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancerNobukazu Fujimoto, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancerKeiichi Fujiwara, Nobukazu Fujimoto, Masahiro Tabata, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2015
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesotheliomaTomoko Yamagishi, Nobukazu Fujimoto, Hideyuki Nishi, et al.
Cancer Science|December 8, 2011
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaMasanori Fujii, Nobukazu Fujimoto, Akio Hiraki, et al.
JTO Clinical and Research Reports|September 30, 2021
Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT StudyNobukazu Fujimoto, Morihito Okada, Takashi Kijima, et al.
Oncology Reports|January 5, 2007
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationKatsuyuki Hotta, Masahiro Tabata, Katsuyuki Kiura, et al.
Pageof 11